Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 9, 2007, Pages 986-991

  Giampaglia, Carmen Maria Saraiva ^a   Martins, M C ^a   De Oliveira Vieira, G B ^b   Vinhas, S A ^c   Da Silva Telles, M A ^a   Palaci, M ^c   Marsico, A G ^b   Hadad, D J ^c   Mello, F C Q ^b   De Souza Fonseca, L ^b   Kritski, A ^b  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

BACTEC 460; MGIT 960; Mycobacterium tuberculosis; Proportion method; Resistance ratio method; Susceptibility

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIAL GROWTH; BACTERIUM ISOLATE; BRAZIL; COMPARATIVE STUDY; CONTROLLED STUDY; LABORATORY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RADIOMETRY;

EID: 34548708533     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Laszlo A, Rahman M, Espinal M, Raviglione M. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing. 1994-1998. Int Tuberc Lung Dis 2002; 6: 748-756.
2. Scarparo C, Ricordi P, Ruggiero G, Piccoli P. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampicin and ethambutol and comparison with the radiometric BACTEC 460TB method. J Clin Microbiol 2004; 42: 1109-1114.
3. Siddiqi S H. BACTEC 460 TB System: product and procedure manual. Sparks, MD, USA: Becton Dickinson Microbiology Systems, 1996.
4. Macondo E A, Ba F, Toure-Kane N C, et al. Improvement of tuberculosis diagnosis by the Mycobacteria Growth Indicator Tube (MGIT) in a developing country laboratory. Bull Soc Pathol Exot 2000; 93: 97-100.
5. Palaci M, Ueki S Y, Sato D N, Telles M A S, Curcio M, Silva E A. Evaluation of Mycobacteria Growth Indicator Tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens. J Clin Microbiol 1996; 34: 762-764.
6. Adjers-Koskela K, Katila M L. Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis. J Clin Microbiol 2003; 41: 1235-1239.
7. Ardito F, Posteraro B, Sanguinetti M, Zanetti S, Fadda G. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2001; 39: 4440-4444.
8. Bemer P, Palicova F, Rüsch-Gerdes S, Drugeon H B, Pfyffer G E. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 150-154.
9. Marttila H J, Marjamaki M, Viljanen M K, Soini H. Performance of BACTEC 960 Mycobacteria Growth Indicator Tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis 2003; 22: 757-759.
10. Tortoli E, Benedetti M, Fontanelli A, Simonetti M T. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major anti-tuberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol 2002; 40: 607-610.
11. Kontos F, Maniati M., Costopoulos C, et al. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J Microbiol Methods 2004; 56: 291-294.
12. Collins C H, Grange J M, Yates M D. Tuberculosis bacteriology organization and practice. 2nd ed. Oxford, UK: Butterworth-Heinemann, 1997.
13. Kent P T, Kubica G P. Public health mycobacteriology. A guide for a level III laboratory. Atlanta, GA, USA: Centers for Disease Control, 1985.
14. Fundação Nacional de Saúde, Centro de Referência Professor Hélio Fraga. Manual de bacteriologia da tuberculose. 2nd ed. Rio de Janeiro, Brazil: Ministério da Saúde, 1994.
15. Becton Dickinson & Co. BBL MGIT products for the detection of mycobacteria. Cockcysville, MD, USA: Becton Dickinson Microbiology System, 1994.
16. Dye C, Watt C J, Bleed D M, Hosseini S M, Raviglione M C. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 2005; 293: 2767-2775.
17. Mukherjee J S, Rich M L, Socci A R, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004; 363: 474-481.
18. Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol 2006; 44: 20-28.
19. Johansen I S, Thomsen V O, Marjamaki M, Sosnovskaja A, Lundgren B. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy. Diagn Microbiol Infect Dis 2004; 50: 103-107.
20. Madison B, Robinson-Dunn B, George I, et al. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol 2002; 40: 3976-3979.
21. Alcaide F, Pfyffer G E, Telenti A. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 1997; 41: 2270-2273.
22. Sreevatsan S, Stockbauer K E, Pan X, et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997; 41: 1677-1681.
23. Rüsch-Gerdes S, Domehl C, Nardi G, Gismondo M R, Welscher H M, Pfyffer G E. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol 1999; 37: 45-48.
24. Ministério da Saúde. Indicadores de morbidade e fatores de risco. Brasilia, Brazil: Ministério da Saúde. http://tabnet. datasus.gov.br Accessed 5 April 2007.